Table 3.
Incidence And Severity Of ALBI, APRI And Combination ALBI-APRI Scores For Predicting PHLF
| ALBI Score | APRI Score | ALBI-APRI Score | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ≤ −2.77 (n=537) | > −2.77 (n=518) | P Value | ≤ 0.85 (n=700) | > 0.85 (n=355) | P Value | ≤ −13.10 (n=595) | > −13.10 (n=460) | P Value | |
| PHLF | 33 (6.1%) | 118 (22.8%) | < 0.001 | 58 (8.3%) | 93 (26.2%) | < 0.001 | 33 (5.5%) | 118 (25.7%) | < 0.001 |
| PHLF A | 17 (3.2%) | 37 (7.1%) | < 0.001 | 22 (3.1%) | 32 (9.0%) | < 0.001 | 15 (2.5%) | 39 (8.5%) | < 0.001 |
| PHLF B | 16 (3.0%) | 68 (13.1%) | < 0.001 | 31 (4.4%) | 53 (14.9%) | < 0.001 | 17 (2.9%) | 67 (14.6%) | < 0.001 |
| PHLF C | 0 (0%) | 13 (2.5%) | < 0.001 | 5 (0.7%) | 8 (2.3%) | < 0.001 | 1 (0.2%) | 12 (2.6%) | < 0.001 |
Abbreviations: ALBI, albumin–bilirubin; APRI, aspartate aminotransferase to platelet ratio index; ALBI-APRI, combination of ALBI and APRI; PHLF, post-hepatectomy liver failure.